Type 1 diabetes trials in Spain

In Spain 31 Also abroad 539

31 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseEnrolling by invitation
SMARTCLOTH. Design, Implementation and Study of the Effectiveness and Usability of a Digital Tablecloth for Self-management of Diet in Diabetic Patients.
Where
Córdoba
Age
18 years to 70 years
People
90
Run by
Maimónides Biomedical Research Institute of Córdoba
See details and how to joinNCT06623708
No phaseNot yet taking people in Spain
Impact of Dietary Fat and Menstrual Cycle Phases in Type 1 Diabetes
Where
Valencia
Age
18 years to 45 years
People
50
Run by
Instituto de Investigacion Sanitaria La Fe
See details and how to joinNCT07278063
No phaseTaking people
Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
Where
Madrid, Zaragoza
People
60 worldwide
Run by
Sanofi
See details and how to joinNCT07457580
No phaseTaking people
Estimated Risk of Preeclampsia in the First Trimester and Its Association With Subclinical Atherosclerosis and Cardiovascular Risk in Women With Type 1 Diabetes
Where
Barcelona, Terrassa
Age
18 years and over
People
1,300
Run by
Institut d'Investigacions Biomèdiques August Pi i Sunyer
See details and how to joinNCT07479329
Phase 3Taking people
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Where
Barakaldo, Esplugues de Llobregat, Madrid
Age
1 year to 35 years
People
150 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07222137 · EU 2025-521797-34-00
Phase 3Taking people
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Where
Barakaldo, Barcelona, Esplugues de Llobregat, Madrid, Santander, Sevilla, Valencia
Age
1 year to 35 years
People
300 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07222332 · EU 2025-522170-36-00
No phaseTaking people
Effectiveness of a Combined mHealth-CBT Psychological Intervention to Improve Psychological Well-Being in Young Patients With T1D
Where
Córdoba
Age
6 years to 18 years
People
122
Run by
Maimónides Biomedical Research Institute of Córdoba
See details and how to joinNCT06450730
Phase 3Taking people
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Where
Alcalá de Henares, Barcelona, Bizkaia, Esplugues de Llobregat, Madrid, Málaga, Palma, Pamplona, Sabadell, San Cristóbal de La Laguna, Santiago de Compostela, Seville, Vigo
Age
1 year to 25 years
People
723 worldwide
Run by
Sanofi
See details and how to joinNCT07088068
Phase 2Taking people
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Where
Barakaldo, Málaga, Sevilla
Age
5 years to 40 years
People
159 worldwide
Run by
SAb Biotherapeutics, Inc.
See details and how to joinNCT07187531 · EU 2025-521560-36-00
Phase 3Taking people
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Where
A Coruña, Antequera, Barcelona, Centelles, Fuenlabrada, Girona, Madrid, Málaga, Manresa, Valladolid
Age
18 years and over
People
2,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00
No phaseTaking people
HOME-AHCL: Home-Based Implementation of an Advanced Hybrid Closed-Loop System With Telemonitoring in Type 1 Diabetes
Where
Cartagena, Murcia
Age
18 years and over
People
80
Run by
Air Liquide Healthcare Spain
See details and how to joinNCT07492992
No phaseTaking people
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
Where
Barcelona
Age
18 years to 99 years
People
24,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT05663515
Phase 1Taking people
A multicentre, single-arm, open-label, non-randomised pilot clinical trial to assess the dose-dependent effect of tirzepatide on gastric emptying in adult patients with type 1 diabetes
Where
Madrid, Valencia
Age
18 years and over
People
12
Run by
Fundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Cajal
See details and how to join2026-527062-72-00 · EU 2026-527062-72-00
Phase 3Taking people
A trial to learn how safe elecoglipron is and how well it works in adults living with obesity or excess body weight with or without type 2 diabetes
Where
A Coruna, Almería, Badalona, Barcelona, Castilleja De La Cuesta, León, Madrid, Santander, Santiago de Compostela, Sevilla, Tarragona, Valencia
Age
18 years and over
People
1,010 worldwide
Run by
AstraZeneca AB
See details and how to join2025-524688-19-00 · EU 2025-524688-19-00
No phaseTaking people
Polycystic Ovary Syndrome in Type 1 Diabetes
Where
Madrid
Age
18 years to 45 years
People
60
Run by
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
See details and how to joinNCT07490964
Phase 3Taking people
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Where
A Coruña, Barcelona, Móstoles, Sanlúcar de Barrameda, Santiago de Compostela, Segovia, Valencia
Age
45 years and over
People
1,778 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07797335
No phaseTaking people
Dietary Approaches for the Management of Overweight and Obesity in Type 1 Diabetes
Where
Málaga
Age
18 years to 65 years
People
75
Run by
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
See details and how to joinNCT07667504
No phaseNot yet taking people in Spain
Butyrate or Intensive Lifestyle Modification in Type 1 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
Where
Málaga
Age
18 years to 75 years
People
200
Run by
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
See details and how to joinNCT07684248
No phaseTaking people
DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic Conditions
Where
Seville
Age
18 years and over
People
280
Run by
Adhera Health, Inc.
See details and how to joinNCT07638345
No phaseTaking people
EmoTIChealth: Promoting Adolescent Health Through a Serious Game.
Where
Valencia
Age
12 years to 16 years
People
600
Run by
University of Valencia
See details and how to joinNCT07212530
No phaseNot yet taking people in Spain
Evaluation of the Safety and Effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in Adults Living With Type 1 Diabetes
Where
Barcelona, Madrid
Age
18 years and over
People
230 worldwide
Run by
Medtronic MiniMed, Inc.
See details and how to joinNCT07401901
No phaseTaking people
CONCEPTT Kids International Neurodevelopmental Outcomes Among Offspring of Women With Type 1 Diabetes
Where
Barcelona
Age
6 years and over
People
225 worldwide
Run by
University of Manitoba
See details and how to joinNCT05754567
No phaseTaking people
Characterization of Type 1 Diabetes Subgroup: An Artificial Intelligence Analysis of Clinical and Glucometric Features
Where
Barcelona
Age
18 years and over
People
800
Run by
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
See details and how to joinNCT07461805
No phaseTaking people
Evaluation of a Mobile AI-powered Decision Support System for Insulin Dosing and Glucose Prediction in Type 1 Diabetes: The glUCModel Clinical Trial Protocol
Where
Madrid, Toledo
Age
18 years to 65 years
People
34
Run by
Universidad Complutense de Madrid
See details and how to joinNCT07304778
No phaseTaking people
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
Where
Valencia
Age
18 years to 90 years
People
250
Run by
Cardenal Herrera University
See details and how to joinNCT07309094